Jeil Pharmaceutical Co Ltd Cash Flow Quality Index
Jeil Pharmaceutical Co Ltd cash flow quality index. Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Quality Index of 0.07x as of December 2025. Operating cash flow of ₩532.03 Million is below net income of ₩7.36 Billion, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Jeil Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jeil Pharmaceutical Co Ltd (2017–2025)
Cash flow quality index of Jeil Pharmaceutical Co Ltd from 2017 to 2025. Historical Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jeil Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Jeil Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2017–2025)
Jeil Pharmaceutical Co Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Jeil Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd (271980) cash conversion ratio.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.24x | ₩-5.69 Billion | ₩23.38 Billion | ▲ +75.6% |
| 2023 | -1.00x | ₩-4.98 Billion | ₩5.00 Billion | ▲ +63.9% |
| 2020 | -2.75x | ₩-19.05 Billion | ₩6.92 Billion | ▼ -124.2% |
| 2018 | 11.36x | ₩21.45 Billion | ₩1.89 Billion | ▲ +388.0% |
| 2017 | -3.94x | ₩-4.21 Billion | ₩1.07 Billion | — |